These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 7822107
1. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy. Segawa M, Ohno Y, Doi M, Inoue M, Ishida T, Iwashita T. Int J Pept Protein Res; 1994 Sep; 44(3):295-304. PubMed ID: 7822107 [Abstract] [Full Text] [Related]
2. Solution conformation of mu-selective dermorphin and delta-selective deltorphin-I in phospholipid micelles, studied by NMR spectroscopy and molecular dynamics simulations. Segawa M, Ohno Y, Doi M, Ishida T, Iwashita T. Int J Pept Protein Res; 1995 Jul; 46(1):37-46. PubMed ID: 7558595 [Abstract] [Full Text] [Related]
3. Conformation of deltorphin-II in membrane environment studied by two-dimensional NMR spectroscopy and molecular dynamics calculations. Ohno Y, Segawa M, Ohishi H, Doi M, Kitamura K, Ishida T, Inoue M, Iwashita T. Eur J Biochem; 1993 Feb 15; 212(1):185-91. PubMed ID: 8383038 [Abstract] [Full Text] [Related]
8. Folded conformations of the delta-selective opioid dermenkephalin with head-to-tail interactions. A simulated annealing study through NMR restraints. Naim M, Nicolas P, Baron D. Int J Pept Protein Res; 1996 May 15; 47(5):353-60. PubMed ID: 8791158 [Abstract] [Full Text] [Related]
10. Conformational properties of deltorphin: new features of the delta-opioid receptor. Temussi PA, Picone D, Tancredi T, Tomatis R, Salvadori S, Marastoni M, Balboni G. FEBS Lett; 1989 Apr 24; 247(2):283-8. PubMed ID: 2541018 [Abstract] [Full Text] [Related]
11. Bioactivity of new mu and delta opioid peptides. Capasso A. Med Chem; 2007 Sep 24; 3(5):480-7. PubMed ID: 17897075 [Abstract] [Full Text] [Related]
12. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor. Amiche M, Sagan S, Mor A, Delfour A, Nicolas P. Mol Pharmacol; 1989 Jun 24; 35(6):774-9. PubMed ID: 2543911 [Abstract] [Full Text] [Related]
13. Solution conformations of deltorphin-I obtained from combined use of quantitative 2D-NMR and energy calculations: a comparison with dermenkephalin. Naim M, Nicolas P, Benajiba A, Baron D. J Pept Res; 1998 Dec 24; 52(6):443-56. PubMed ID: 9924989 [Abstract] [Full Text] [Related]
14. Folding trends in a flexible peptide: two-dimensional NMR study of deltorphin-I, a delta selective opioid heptapeptide. Duchesne D, Naim M, Nicolas P, Baron D. Biochem Biophys Res Commun; 1993 Sep 15; 195(2):630-6. PubMed ID: 8373402 [Abstract] [Full Text] [Related]
15. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor. Amiche M, Sagan S, Mor A, Pelaprat D, Rostene W, Delfour A, Nicolas P. Eur J Biochem; 1990 May 20; 189(3):625-35. PubMed ID: 2161761 [Abstract] [Full Text] [Related]
16. Molecular dynamics conformations of deltorphin analogues advocate delta opioid binding site models. Bryant SD, Attila M, Salvadori S, Guerrini R, Lazarus LH. Pept Res; 1994 May 20; 7(4):175-84. PubMed ID: 7696838 [Abstract] [Full Text] [Related]
17. The mu-selective heptapeptide opioid dermorphin has two conformations around Phe3 psi with no head-to-tail interaction. A quantitative 2-D NMR and molecular modeling analysis. Riand J, Nicolas P, Baron D. J Biomol Struct Dyn; 2002 Dec 20; 20(3):359-73. PubMed ID: 12437374 [Abstract] [Full Text] [Related]
18. Conformational comparison of mu-selective endomorphin-2 with its C-terminal free acid in DMSO solution, by 1H NMR spectroscopy and molecular modeling calculation. In Y, Minoura K, Ohishi H, Minakata H, Kamigauchi M, Sugiura M, Ishida T. J Pept Res; 2001 Nov 20; 58(5):399-412. PubMed ID: 11892849 [Abstract] [Full Text] [Related]
19. Conformational restriction of Tyr and Phe side chains in opioid peptides: information about preferred and bioactive side-chain topology. Tourwé D, Verschueren K, Frycia A, Davis P, Porreca F, Hruby VJ, Toth G, Jaspers H, Verheyden P, Van Binst G. Biopolymers; 1996 Jan 20; 38(1):1-12. PubMed ID: 8679939 [Abstract] [Full Text] [Related]
20. pKa and volume of residue one influence delta/mu opioid binding: QSAR analysis of tyrosine replacement in a nonselective deltorphin analogue. Heyl DL, Schullery SE, Renganathan K, Jayamaha MN, Rodgers DW, Traynor JR. Bioorg Med Chem; 2003 Aug 15; 11(17):3761-8. PubMed ID: 12901921 [Abstract] [Full Text] [Related] Page: [Next] [New Search]